Human Genotyping Arrays
Our Human Genotyping Arrays provide you with the greatest statistical power to detect trait and disease-associated variants available at a range of different scales. Optimized using data from the 1000 Genomes Project, Illumina Infinium arrays provide coverage of up to ~2 million markers targeting genome-wide and functional exonic variants in cost-effective, high-throughput assays.
Human Psych Array Get a Quote
- Genome and exome coverage plus content targeted to psychiatric disease
- >580,000 genome-wide and exonic markers plus 50,000 psychiatric disease markers
The Human Psych Array offers content targeted to studies of psychiatric disease. It features >260,000 genome-wide markers and >270,000 functional exonic markers as well as >50,000 additional markers selected by a consortium of psychiatric genomics experts from leading institutions including the Stanley Center for Psychiatric Research. Includes analysis that delivers SNP calls shortly after processing in the laboratory and is compatible with other industry analysis tools. Call rates typically exceed 97%.
Human Multi-Ethnic Array (MEGA) Get a Quote
- Multipurpose, multi-ethnic array providing tremendous scope
- 1.7 million genome-wide markers
The Multi-Ethnic Genotyping Array, (MEGA), can detect both common and rare variants across the most commonly studied 5 major super-populations and impute variants in a vast number of subpopulations, utilizing population-specific and transethnic tag SNPs. Includes analysis that delivers SNP calls shortly after processing in the laboratory and is compatible with other industry analysis tools. Call rates typically exceed 98%.
Global Screening Array (GSA) Get a Quote
- Multi-ethnic genome-wide content, curated clinical research variants, quality control (QC) markers for precision medicine
- >640,000 total markers
The Global Screening Array (GSA) is an advanced genotyping array for population-scale genetic studies, variant screening, and precision medicine research. Featuring >575,000 genome-wide markers and >66,000 exonic markers and selected by a consortium of human disease researchers, health care networks, consumer genomics companies, and genomic service providers it allows for optimized global content supporting high-throughput processing of samples. Includes analysis in our state of the art calling pipeline that delivers SNP calls shortly after processing in the laboratory and is compatible with other industry analysis tools. Call rates typically exceed 98%.